Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium
- PMID: 7500435
- DOI: 10.7863/jum.1995.14.9.685
Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium
Abstract
Most menopausal patients with breast cancer receive tamoxifen therapy. In these patients, TVS may show thickened, irregular cystic endometria. For better visualization of these patients' uterine cavities, we performed transvaginal sonohysterography. During vaginal ultrasonography, sterile saline was introduced by transcervical 8 French Foley catheter into the uterine cavity of 20 women who were referred with tamoxifen-associated cystic thickened endometria. In eight women, transvaginal sonohysterography provided the means to diagnose occult, free-floating endometrial polyps, whereas in 12 women, the fluid contrast augmented the diagnosis of an irregular cystic endometrial-myometrial junction. All 20 patients underwent diagnostic hysteroscopy: eight polyps, none of which were malignant, were confirmed and removed by hysteroscopic resection. Of the remaining 12 patients with an irregular endometrial-myometrial junction, endometrial curettage showed no significant pathologic findings. Transvaginal sonohysterography seems to enhance the differentiation between endometrial polyps that should be resected by operative hysteroscopy and an abnormal endometrial-myometrial junction that may benefit from biopsy sampling only.
Similar articles
-
Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.Am J Obstet Gynecol. 1998 Jun;178(6):1145-50. doi: 10.1016/s0002-9378(98)70315-1. Am J Obstet Gynecol. 1998. PMID: 9662294
-
Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.AJR Am J Roentgenol. 2001 Aug;177(2):337-42. doi: 10.2214/ajr.177.2.1770337. AJR Am J Roentgenol. 2001. PMID: 11461858
-
Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):62-7. doi: 10.1016/s1074-3804(05)60013-8. J Am Assoc Gynecol Laparosc. 2004. PMID: 15104834
-
Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.Yonsei Med J. 2020 Apr;61(4):317-322. doi: 10.3349/ymj.2020.61.4.317. Yonsei Med J. 2020. PMID: 32233174 Free PMC article. Review.
-
[Benign endometrial lesions induced by tamoxifen].J Gynecol Obstet Biol Reprod (Paris). 1999 Sep;28(5):420-4. J Gynecol Obstet Biol Reprod (Paris). 1999. PMID: 10566160 Review. French.
Cited by
-
Tamoxifen and secondary tumours. An update.Drug Saf. 1997 Feb;16(2):104-17. doi: 10.2165/00002018-199716020-00003. Drug Saf. 1997. PMID: 9067122 Review.
-
Section 8--clinical relevance. American Institute of Ultrasound in Medicine.J Ultrasound Med. 2000 Feb;19(2):149-68. doi: 10.7863/jum.2000.19.2.149. J Ultrasound Med. 2000. PMID: 10680620 Free PMC article. Review. No abstract available.
-
Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.J Ultrasound Med. 2000 Feb;19(2):120-42, 154-68. doi: 10.7863/jum.2000.19.2.120. J Ultrasound Med. 2000. PMID: 10680618 Free PMC article. Review.
-
Cancer of the endometrium: current aspects of diagnostics and treatment.World J Surg Oncol. 2004 Jul 21;2:24. doi: 10.1186/1477-7819-2-24. World J Surg Oncol. 2004. PMID: 15268760 Free PMC article.
-
Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.J Ultrasound Med. 2000 Feb;19(2):143-8, 154-68. doi: 10.7863/jum.2000.19.2.143. J Ultrasound Med. 2000. PMID: 10680619 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources